Soft inflation data lifted major U.S. stock indexes Tuesday morning, except for one notable exception: the Dow Jones Industrial Average, the blue-chip index that for many is synonymous with “the stock ...

Foreign stocks in developed markets ex-US are still the global performance leader by far in 2025, based on a set of ETFs ...

U.S. equities were mixed at midday, with tech shares and a better-than-expected consumer inflation report lifting the S&P 500 ...

The S&P 500 and Nasdaq 100 indexes turned higher for the year on Tuesday, reversing a multitrillion dollar routs, as ...

Investors have been buying up dividend stocks in droves in recent months due to broader market volatility. This doesn’t ...

Paul Nolte, Senior Wealth Advisor & Market Strategist for Murphy & Sylvest, joins Bob Sirott to talk about how the markets are reacting to tariff negotiations with China. He also shares ...

Right now, the momentum certainly seems to favor the bulls. Since the S&P 500 fell to the cusp of bear-market territory on April 8, stocks have staged an impressive comeback, with the index rising ...

The U.S. will drop its tariffs to 30% (due to the 20% “fentanyl tariffs”), and China will drop its tariffs to 10%. The market ...

For investors looking to create meaningful and reliable income streams for retirement (or any other reason, for that matter), ...

My rating for ORIX Corporation is lowered from Buy to Hold, considering its short-term prospects and mid-term targets. ORIX's ...

Quantum computing hype has fueled IonQ's impressive returns, but investors could be overly harsh toward an up-and-coming ...

Two biotech stocks make perfect candidates for this sort of strategy right now. Let's take a close look at these two biotech ...